Association Between Diabetes Mellitus and Post-stroke Cognitive Impairment

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2022 Oct 1

PMID 36181402

Authors

Kang-Po Lee

Jung-Sheng Chen

Chih-Yuan Wang

Affiliations

Soon will be listed here.

Abstract

Stroke survivors suffer from various physical, emotional, and cognitive impairments. These changes are dynamic and depend on multiple factors, including underlying diseases, baseline brain function and pathology, the site of the stroke and the post-stroke inflammation, neurogenesis as well as the subsequent remodeling of the neuro-network. First we review the structural and pathological changes of the brain in stroke survivors with diabetes mellitus, which may lead to post-stroke cognitive dysfunction. Second, we provide evidence of hyperglycemia, diabetes mellitus, hypoglycemia, and their relationship with post-stroke cognitive impairment (PSCI) and post-stroke dementia (PSD). In addition to conventional biomarkers, such as HbA1c, we also provide other novel tools to predict PSCI/PSD, such as glycemic variability, receptor for advanced glycation end products, and gut microbiota. Finally, we attempt to provide some modifying methods for glycemic control, focusing on the prevention of PSCI/PSD.

Citing Articles

lncRNA six3os1 diagnoses acute stroke, predicts disease severity, and predicts post-stroke cognitive impairment.

Liu Y, Wang R, Zeng J, Zhao W, Xiao Y, Jiang H BMC Neurol. 2024; 24(1):491.

PMID: 39722013 PMC: 11670514. DOI: 10.1186/s12883-024-04003-5.

Antihyperglycemic and Hypolipidemic Activities of Flavonoids Isolated from Smilax Dominguensis Mediated by Peroxisome Proliferator-Activated Receptors.

Ortiz-Barragan E, Estrada-Soto S, Giacoman-Martinez A, Alarcon-Aguilar F, Fortis-Barrera A, Marquina-Rodriguez H Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598363 PMC: 11597028. DOI: 10.3390/ph17111451.

Impact of diverse aerobic exercise plans on glycemic control, lipid levels, and functional activity in stroke patients with type 2 diabetes mellitus.

Chen K, Wang Y, Li D, Li J, Huang Y, Huang M Front Endocrinol (Lausanne). 2024; 15:1389538.

PMID: 39359413 PMC: 11446103. DOI: 10.3389/fendo.2024.1389538.

Risk factors for post-cerebral infarction cognitive dysfunction in older adults: a retrospective study.

Ma F, Zhang Q, Li J, Wu L, Zhang H BMC Neurol. 2024; 24(1):72.

PMID: 38378548 PMC: 10877785. DOI: 10.1186/s12883-024-03574-7.

Prediction of poststroke cognitive impairment based on the systemic inflammatory response index.

Chu M, Luo Y, Wang D, Liu Z, Niu H, Wu X Brain Behav. 2024; 14(1):e3372.

PMID: 38376025 PMC: 10771225. DOI: 10.1002/brb3.3372.

References

Shang Y, Fratiglioni L, Marseglia A, Plym A, Welmer A, Wang H . Association of diabetes with stroke and post-stroke dementia: A population-based cohort study. Alzheimers Dement. 2020; 16(7):1003-1012. DOI: 10.1002/alz.12101. View

Mizrahi E, Waitzman A, Blumstein T, Arad M, Adunsky A . Diabetes mellitus predicts cognitive impairment in patients with ischemic stroke. Am J Alzheimers Dis Other Demen. 2010; 25(4):362-6. PMC: 10845612. DOI: 10.1177/1533317510365343. View

Lim J, Kim C, Oh M, Lee J, Jung S, Jang M . Effects of glycemic variability and hyperglycemia in acute ischemic stroke on post-stroke cognitive impairments. J Diabetes Complications. 2018; 32(7):682-687. DOI: 10.1016/j.jdiacomp.2018.02.006. View

Lee M, Lim J, Kim Y, Lee J, Kim C, Lee S . Effects of Glycemic Gap on Post-Stroke Cognitive Impairment in Acute Ischemic Stroke Patients. Brain Sci. 2021; 11(5). PMC: 8151287. DOI: 10.3390/brainsci11050612. View

Ding M, Xu Y, Wang Y, Li P, Mao Y, Yu J . Predictors of Cognitive Impairment After Stroke: A Prospective Stroke Cohort Study. J Alzheimers Dis. 2019; 71(4):1139-1151. DOI: 10.3233/JAD-190382. View

Zullo A, Duprey M, Smith R, Gutman R, Berry S, Munshi M . Effects of dipeptidyl peptidase-4 inhibitors and sulphonylureas on cognitive and physical function in nursing home residents. Diabetes Obes Metab. 2021; 24(2):247-256. PMC: 8741644. DOI: 10.1111/dom.14573. View

Jackson L, Dumanli S, Johnson M, Fagan S, Ergul A . Microglia knockdown reduces inflammation and preserves cognition in diabetic animals after experimental stroke. J Neuroinflammation. 2020; 17(1):137. PMC: 7189436. DOI: 10.1186/s12974-020-01815-3. View

Baric A, Dobrivojevic Radmilovic M . Microglia and bradykinin cross talk in poststroke cognitive impairment in diabetes. Am J Physiol Cell Physiol. 2021; 320(4):C613-C618. DOI: 10.1152/ajpcell.00402.2020. View

Aam S, Gynnild M, Munthe-Kaas R, Saltvedt I, Lydersen S, Knapskog A . The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study. Front Neurol. 2021; 12:678794. PMC: 8374055. DOI: 10.3389/fneur.2021.678794. View

10.

Jackson L, Li W, Abdul Y, Dong G, Baban B, Ergul A . Diabetic Stroke Promotes a Sexually Dimorphic Expansion of T Cells. Neuromolecular Med. 2019; 21(4):445-453. PMC: 6884673. DOI: 10.1007/s12017-019-08554-6. View

11.

Lo J, Crawford J, Samaras K, Desmond D, Kohler S, Staals J . Association of Prediabetes and Type 2 Diabetes With Cognitive Function After Stroke: A STROKOG Collaboration Study. Stroke. 2020; 51(6):1640-1646. DOI: 10.1161/STROKEAHA.119.028428. View

12.

Tang S, Yang K, Hu C, Chiou H, Wu C, Jeng J . Elevated Plasma Level of Soluble Form of RAGE in Ischemic Stroke Patients with Dementia. Neuromolecular Med. 2017; 19(4):579-583. PMC: 5683059. DOI: 10.1007/s12017-017-8471-9. View

13.

Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C . Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713. PMC: 3778669. DOI: 10.1161/STR.0b013e3182299496. View

14.

Low S, Goh K, Ng T, Moh A, Ang S, Wang J . Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 Diabetes. J Alzheimers Dis. 2022; 87(2):635-642. DOI: 10.3233/JAD-215678. View

15.

Imfeld P, Bodmer M, Jick S, Meier C . Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study. J Am Geriatr Soc. 2012; 60(5):916-21. DOI: 10.1111/j.1532-5415.2012.03916.x. View

16.

Risner M, Saunders A, Altman J, Ormandy G, Craft S, Foley I . Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 2006; 6(4):246-54. DOI: 10.1038/sj.tpj.6500369. View

17.

Morris P, Robinson R, Raphael B . Emotional lability after stroke. Aust N Z J Psychiatry. 1993; 27(4):601-5. DOI: 10.3109/00048679309075822. View

18.

Jacquin A, Binquet C, Rouaud O, Graule-Petot A, Daubail B, Osseby G . Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke. J Alzheimers Dis. 2014; 40(4):1029-38. DOI: 10.3233/JAD-131580. View

19.

Klimkowicz-Mrowiec A, Dziedzic T, Slowik A, Szczudlik A . Predictors of poststroke dementia: results of a hospital-based study in poland. Dement Geriatr Cogn Disord. 2006; 21(5-6):328-34. DOI: 10.1159/000091788. View

20.

Koszewicz M, Jaroch J, Brzecka A, Ejma M, Budrewicz S, Mikhaleva L . Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res. 2020; 164:105277. DOI: 10.1016/j.phrs.2020.105277. View